• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年甲型血友病、乙型血友病和血管性血友病患者的治疗依从性与生活质量:一项全国性横断面调查。

Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross-Sectional Survey.

作者信息

Clausen Cecilie Maria Lüthje, Funding Eva, Tolver Anders, Jarden Mary

机构信息

Copenhagen Haemophilia Centre, Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

出版信息

Eur J Haematol. 2025 Jan;114(1):164-172. doi: 10.1111/ejh.14324. Epub 2024 Oct 10.

DOI:10.1111/ejh.14324
PMID:39390782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11613627/
Abstract

BACKGROUND

New treatments for patients with bleeding disorders (PWB) have emerged, including products with extended half-life and subcutaneous administration. These less frequent treatments can potentially enhance quality of life (QoL), but adherence becomes critically important.

AIM

To investigate adherence and QoL among PWB and explore the correlation between treatment adherence and QoL in adult patients with haemophilia A (HA), haemophilia B (HB) and Von Willebrand disease (vWD) in Denmark.

METHOD

This survey used disease-specific patient-reported questionnaires: Veritas-PRO and Veritas-PRN to measure adherence, and Haemo-A-QoL and VWD-QoL to assess QoL.

RESULTS

Responses were obtained from 149 patients with HA, 32 with HB and 118 with vWD. Adherence was reported by 87.1% of patients on prophylaxis and 71.2% of patients treated on demand, according to Veritas-PRO and Veritas-PRN cut-off scores. High QoL was generally reported, decreasing with age in HA and HB, but not in vWD.

CONCLUSION

Danish patients with HA, HB and vWD reported high QoL and high adherence to prescribed treatments. There was no correlation between treatment adherence and QoL among the different patient groups. These findings highlight the need for further research to better understand adherence behaviours and identify opportunities to further improve QoL in PWB.

摘要

背景

针对出血性疾病患者(PWB)出现了新的治疗方法,包括半衰期延长的产品和皮下给药方式。这些给药频率较低的治疗方法有可能提高生活质量(QoL),但依从性变得至关重要。

目的

调查丹麦成年甲型血友病(HA)、乙型血友病(HB)和血管性血友病(vWD)患者的依从性和生活质量,并探讨治疗依从性与生活质量之间的相关性。

方法

本调查使用了针对特定疾病的患者报告问卷:Veritas-PRO和Veritas-PRN来测量依从性,Haemo-A-QoL和VWD-QoL来评估生活质量。

结果

共获得149例HA患者、32例HB患者和118例vWD患者的回复。根据Veritas-PRO和Veritas-PRN的截断分数,87.1%接受预防治疗的患者和71.2%按需治疗的患者报告了依从性。总体报告的生活质量较高,在HA和HB中随年龄下降,但在vWD中没有。

结论

丹麦的HA、HB和vWD患者报告生活质量高,对规定治疗的依从性高。不同患者组之间的治疗依从性与生活质量之间没有相关性。这些发现凸显了进一步研究的必要性,以更好地理解依从行为,并确定进一步改善出血性疾病患者生活质量的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11a/11613627/e8979471c06c/EJH-114-164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11a/11613627/43e91b4f130e/EJH-114-164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11a/11613627/e8979471c06c/EJH-114-164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11a/11613627/43e91b4f130e/EJH-114-164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11a/11613627/e8979471c06c/EJH-114-164-g002.jpg

相似文献

1
Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross-Sectional Survey.成年甲型血友病、乙型血友病和血管性血友病患者的治疗依从性与生活质量:一项全国性横断面调查。
Eur J Haematol. 2025 Jan;114(1):164-172. doi: 10.1111/ejh.14324. Epub 2024 Oct 10.
2
Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder.患有出血性疾病的青少年和青年成人中不坚持规定的预防性凝血因子治疗方案的预测因素。
Haemophilia. 2016 Jul;22(4):e245-50. doi: 10.1111/hae.12951. Epub 2016 May 24.
3
[Haemophilia A, B or von Willebrand disease type 3. Census of patients in the eastern part of Germany].[甲型血友病、乙型血友病或3型血管性血友病。德国东部患者普查]
Hamostaseologie. 2008;28(3):150-4.
4
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey.意大利先天性凝血障碍国家登记处 2016 年度调查的新数据。
Blood Transfus. 2020 Jan;18(1):58-66. doi: 10.2450/2019.0211-18. Epub 2019 Feb 13.
5
Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc Analysis.血管性血友病与血友病 A 关节出血后长期结局比较:一项事后分析。
Thromb Haemost. 2018 Oct;118(10):1690-1700. doi: 10.1055/s-0038-1670704. Epub 2018 Oct 1.
6
Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.血管性血友病患者的关节出血对生活质量和关节完整性有重大影响:一项横断面研究。
Haemophilia. 2015 May;21(3):e185-e192. doi: 10.1111/hae.12670. Epub 2015 Apr 9.
7
VERITAS-PRN: a new measure of adherence to episodic treatment regimens in haemophilia.VERITAS-PRN:一种评估血友病间歇性治疗方案依从性的新方法。
Haemophilia. 2010 Jan;16(1):47-53. doi: 10.1111/j.1365-2516.2009.02094.x. Epub 2009 Sep 15.
8
Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale.西欧血友病儿科人群的治疗依从性:VERITAS-Pro量表的信度和效度
Haemophilia. 2014 Sep;20(5):616-23. doi: 10.1111/hae.12463. Epub 2014 May 26.
9
Association between reported medication adherence and health-related quality of life in adult patients with haemophilia.报告的药物依从性与成年血友病患者健康相关生活质量之间的关系。
Int J Clin Pharm. 2021 Dec;43(6):1500-1507. doi: 10.1007/s11096-021-01270-x. Epub 2021 Apr 29.
10
Adherence to prophylactic treatment in patients with haemophilia in Germany.德国血友病患者预防性治疗的依从性。
Haemophilia. 2016 Sep;22(5):e367-74. doi: 10.1111/hae.13003. Epub 2016 Jun 28.

本文引用的文献

1
Health and quality of life of patients with haemophilia: A national study of 124 Danish men.血友病患者的健康与生活质量:对124名丹麦男性的全国性研究。
Haemophilia. 2023 Mar;29(2):538-544. doi: 10.1111/hae.14751. Epub 2023 Feb 2.
2
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B.延长半衰期因子浓缩物对甲型和乙型血友病患者报告的健康结局指标的影响。
Res Pract Thromb Haemost. 2021 Oct 11;5(7):e12601. doi: 10.1002/rth2.12601. eCollection 2021 Oct.
3
von Willebrand disease: what does the future hold?
血管性血友病:未来的前景如何?
Blood. 2021 Apr 29;137(17):2299-2306. doi: 10.1182/blood.2020008501.
4
Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.血友病 A 患者(无因子 VIII 抑制剂)的青少年和成年患者的健康相关生活质量和健康状况:一项非干预性研究。
Haemophilia. 2021 May;27(3):398-407. doi: 10.1111/hae.14270. Epub 2021 Feb 12.
5
A feasibility study on two tailored interventions to improve adherence in adults with haemophilia.一项关于两种针对性干预措施以提高成年血友病患者依从性的可行性研究。
Pilot Feasibility Stud. 2020 Dec 1;6(1):189. doi: 10.1186/s40814-020-00723-w.
6
WFH Guidelines for the Management of Hemophilia, 3rd edition.《血友病管理的居家指南》第三版
Haemophilia. 2020 Aug;26 Suppl 6:1-158. doi: 10.1111/hae.14046. Epub 2020 Aug 3.
7
Psychological interventions for people with hemophilia.针对血友病患者的心理干预措施。
Cochrane Database Syst Rev. 2020 Mar 18;3(3):CD010215. doi: 10.1002/14651858.CD010215.pub2.
8
The Perspectives of Adolescents and Young Adults on Adherence to Prophylaxis in Hemophilia: A Qualitative Study.青少年和青年对血友病预防治疗依从性的看法:一项定性研究
Patient Prefer Adherence. 2020 Jan 23;14:163-171. doi: 10.2147/PPA.S232393. eCollection 2020.
9
Hemophilia - Impact of Recent Advances on Management.血友病 - 近期进展对管理的影响。
Indian J Pediatr. 2020 Feb;87(2):134-140. doi: 10.1007/s12098-019-03062-8. Epub 2019 Sep 16.
10
Real-life experience in switching to new extended half-life products at European haemophilia centres.在欧洲血友病中心切换到新的延长半衰期产品的实际经验。
Haemophilia. 2019 Nov;25(6):946-952. doi: 10.1111/hae.13834. Epub 2019 Aug 16.